Characterization of replication defects induced by mutations in the basic domain and C-terminus of HIV-1 matrix

Virology

Volumn 369, Issue 1, 2007, Pages 47-54

  Bhatia, Ajay K ^a   Campbell, Nancy ^a   Panganiban, Antonito ^b   Ratner, Lee ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Envelope Incorporation; Fusion; HIV 1 Matrix

Indexed keywords

GLYCOPROTEIN GP 41;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRION; VIRUS REPLICATION;

AMINO ACIDS, BASIC; CELL LINE; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MODELS, MOLECULAR; MUTATION; PROTEIN STRUCTURE, TERTIARY; SEQUENCE DELETION; VIRION; VIRUS ASSEMBLY; VIRUS INTERNALIZATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 35648979561     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.06.046     Document Type: Article

References (41)

1. Alfadhli, A., Huseby, D., Kapit, E., Colman, D., Barklis, E., in press. The HIV-1 matrix protein assembles on the membranes as a hexamer. J. Virol. 81, 1472-1478.
2. Bhattacharya J., Repik A., and Clapham P.R. Gag regulates association of human immunodeficiency virus type 1 envelope with detergent-resistant membranes. J. Virol. 80 (2006) 5292-5300
3. Bryant M., and Ratner L. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 523-527
4. Buchscacher G.L., and Panganiban A.T. Human immunodeficiency virus vectors for inducible expression of foreign genes. J. Virol. 66 (1992) 2731-2739
5. Bukrinskaya A.G. HIV-1 assembly and maturation. Arch. Virol. 149 (2004) 1067-1082
6. Bukrinsky M.I., Haggerty S., Dempsey M.P., Sharova N., Adzhubei A., Spitz L., Lewis P., Goldfarb D., Emerman M., and Stevenson M. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365 (1993) 666-669
7. Casella C.R., Raffini L.J., and Panganiban A.T. Pleiotropic mutations in the HIV-1 matrix protein that affect diverse steps in replication. J. Virol. 228 (1997) 294-306
8. Dupont S., Sharova N., DeHoratius C., Virbasius C.-M.A., Zhu X., Bukrinskaya A.G., Stevenson M., and Green M.R. A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature 402 (1999) 681-685
9. Forshey B.M., von Schwedler U., Sundquist W.I., and Aiken C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 76 (2002) 5667-5677
10. Freed E.O. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 251 (1998) 1-15
11. Freed E., and Martin M. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69 (1995) 1984-1989
12. Freed E., and Martin M. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70 (1996) 341-351
13. Freed E.O., and Martin M.A. HIVs and Their Replication. Field's Virology. 4th ed. Vol. 2 (2001) 1971-2041
14. Freed E.O., Orenstein J.M., Buckler-White A.J., and Martin M.A. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68 8 (1994) 5311-5320
15. Freed E., Englund G., and Martin M. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J. Virol. 69 6 (1995) 3949-3954
16. Fricks C.E., and Hogle J.M. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J. Virol. 64 (1990) 1935-1945
17. Gallay P., Swingler S., Song J., Bushman F., and Trono D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83 4 (1995) 569-576
18. Guern M., and Levy J. Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotyped virions produced with expanded cellular host range. Proc. Natl. Acad. Sci. 89 (1992) 363-367
19. Haffar O.K., Popov S., Dubrovsky L., Agostini I., Tang H., Pushkarsky T., Nadler S.G., and Bukrinsky M. Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J. Mol. Biol. 299 (2000) 359-368
20. Hill C.P., Worthylake D., Bancroft D.P., Christensen A.M., and Sundquist W.I. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: Implications for membrane association and assembly. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3099-3104
21. Johnston P.B., Dubay J.W., and Hunter E. Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells. J. Virol. 67 (1993) 3077-3086
22. Kaushik R., and Ratner L. Role of human immunodeficiency virus type 1 matrix phosphorylation in an early postentry step of virus replication. J. Virol. 78 (2004) 2319-2326
23. Massiah M.A., Worthylake D., Christensen A.M., Sundquist W.I., Hill C.P., and Summers M.F. Comparison of the NMR and X-ray structures of the HIV-1 matrix protein: evidence for conformational changes during viral assembly. Protein Sci. 5 (1996) 2391-2398
24. Murakami T., Ablan S., Freed E.O., and Tanaka Y. Regulation of human immunodeficiency virus type 1 env-mediated membrane fusion by viral protease activity. J. Virol. 78 (2004) 1026-1031
25. Ono A., Orenstein J.M., and Freed E.O. Role of the Gag Matrix domain in targeting human immunodeficiency virus type 1 assembly. J. Virol. 74 (2000) 2855-2866
26. Ono A., Ablan S.D., Lockett S.J., Nagashima K., and Freed E.O. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 14889-14894
27. Ono A., Waheed A.A., and Freed E.O. Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag. Virology 360 (2007) 27-35
28. Pirounaki M., Vander Heyden N.A., Arens M., and Ratner L. Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line. J. Virol. Methods 85 (2000) 151-162
29. Pontow S.E., Heyden N.V., Wei S., and Ratner L. Actin cytoskeletal reorganizations and coreceptor-mediated activation of Rac during human immunodeficiency virus-induced cell fusion. J. Virol. 78 (2004) 7138-7147
30. Saad J.S., Miller J., Tai J., Kim A., Ghanam R.H., and Summers M.F. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 11364-11369
31. Salzwedel K., Johnston P.B., Roberts S.J., Dubay J.W., and Hunter E. Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 67 (1993) 5279-5288
32. Sauter M., Pelchen-Matthews A., Bron R., Marsh M., LaBranche C., Vance P., Romano J., Haggarty B., Hart T., Lee W., and Hoxie J. An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface. J. Cell Biol. 132 (1996) 795-811
33. Scarlata S., and Carter C. Role of HIV-1 Gag domains in viral assembly. Biochim. Biophys. Acta 1614 (2003) 62-72
34. Scarlata S., Ehrlich L.S., and Carter C.A. Membrane-induced alterations in HIV-1 gag and matrix protein-protein interactions. J. Mol. Biol. 277 (1998) 161-169
35. Spearman P., Wang J.J., Vander Heyden N., and Ratner L. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68 (1994) 3232-3242
36. Spearman P., Horton R., Ratner L., and Kuli-Zade I. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J. Virol. 71 (1997) 6582-6592
37. Tang S., Murakami T., Cheng N., Steven A.C., Freed E.O., and Levin J.G. Human immunodeficiency virus type 1 N-terminal capsid mutants containing cores with abnormally high levels of capsid protein and virtually no reverse transcriptase. J. Virol. 77 (2003) 12592-12602
38. Tang C., Loeliger E., Luncsford P., Kinde I., Beckett D., and Summers M.F. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 517-522
39. Wyma D.J., Jiang J., Shi J., Zhou J., Lineberger J.E., Miller M.D., and Aiken C. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. J. Virol. 78 (2004) 3429-3435
40. Yu X., Yu Q.C., Lee T.H., and Essex M. The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle. J. Virol. 66 (1992) 5667-5670
41. Zhou W., and Resh M. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70 (1996) 8540-8548